If you’re a big fan of throwing good money after bad, you could go bid on this one-mile monstrosity on Bring A Trailer today.

Nationwide customers could find themselves £392 richer next year and it really couldn't be easier. If users of the world's largest building society move their money into a different account for a ...

T-Mobile is the third-largest wireless carrier in the United States, with its popularity largely down to its network coverage and the wide range of tempting offers available. They span from T ...

A 1968 Dodge Charger R/T Hemi, one of the rarest ever produced, up for auction. At auction Mecum Kissimmee, a true four-wheel legend, is set to find a new owner. This 1968 Dodge Charger R/T Hemi ...

For those fretting over the loss of Hemi-powered Dodges, fear not. Dodge announced Friday that ... a simplified lineup consisting of the GT, R/T, and SRT Hellcat. And for now, it appears to ...

Dodge’s new Charger Daytona coupe hits the market first in R/T and Scat Pack trims ... Charger might have lost the V8 magic of the HEMI-powered Challenger, but it will still satisfy muscle ...

Even as Dodge ... liter HEMI V8 R/T variants, and the 717 horsepower 6.2-liter supercharged V8 Hellcat trims. The Scat Pack is a unique trim that stands out from the Dodge Charger and Challenger ...

Dodge says it is extending the production of the HEMI-powered Dodge Durango SRT Hellcat and Dodge Durango R/T models. As I reported earlier, Dodge was already offering four HEMI-powered special ...

For the initial debut, Dodge is offering two models, both in classic Dodge trim names: R/T and Scat Pack ... year Dodge will roll out a new Dodge Challenger and a four-door Charger, powered ...

However, there’s a catch. The Hemi V8 will continue to power the Dodge Durango for one model year: 2025. A press release from the automaker read the decision was made “due in part to market demand and ...

Rapt Therapeutics has charted a new course following the implosion of its lead program, agreeing to pay $35 million for a long-acting challenger to Novartis and Roche’s Xolair. A deal with ...